Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-17
SponsorWashington University School of Medicine

About this trial

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Eligibility criteria

Qualifiers

Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)

Treatment including chemotherapy and/or radiation therapy

Completion of all cancer therapy for at least 6 months and less than 2 years

Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine

Disqualifiers

Undergoing active cancer treatment

Patient under the care of the Late Effects Program at St. Louis Children's Hospital

Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.

Parents and/or patient illiteracy

Trial design

Treatments tested in this trial

  • Highlighting Patients at Risk for Sensory Screening (HPARSS)

Treatment groups

146 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Washington University School of Medicine

Lead sponsor

St. Jude Children's Research Hospital

Collaborator